On Friday, Crown Castle International Corp (NYSE:CCI)’s shares inclined 1.12% to $81.34.
Crown Castle International Corp (CCI) declared that the quarterly dividend on its 4.50% Mandatory Convertible Preferred Stock (“Preferred Stock”) will be paid on August 3, 2015 to holders of record on July 15, 2015. The dividend will be paid in cash at a rate of $1.125 per share of Preferred Stock.
Crown Castle International Corp., together with its auxiliaries, owns, operates, and leases shared wireless infrastructure in the United States and Australia. The company provides towers and other structures, such as rooftops; and distributed antenna systems, a type of small cell network (small cells). It provides access, counting space or capacity to its towers, small cells, and third party land interests via long-term contracts in various forms, counting license, sublease, and lease agreements.
Susquehanna Bancshares Inc (NASDAQ:SUSQ)’s shares gained 0.99% to $14.35.
BB&T Corporation (BBT) declared it has received regulatory approval from the Federal Reserve, the FDIC and all required state regulators to acquire Susquehanna Bancshares, Inc. (SUSQ). The transaction closing is predictable to be effective Aug. 1, 2015, and systems conversion is predictable during the fourth quarter 2015.
Susquehanna Bancshares, Inc. operates as the bank holding company for Susquehanna Bank that provides a range of retail and commercial banking, and financial products and services in the mid-Atlantic region. The company offers retail banking services, counting checking, savings and club accounts, check cards, debit cards, money market accounts, certificates of deposit, individual retirement accounts, home equity lines of credit, residential mortgage loans, home improvement loans, automobile loans, personal loans, and Internet and mobile banking services.
At the end of Friday’s trade, Infinera Corp. (NASDAQ:INFN)‘s shares surged 2.59% to $20.21.
Infinera Corporation (NASDAQ: INFN) declared that it will release its financial results for the second quarter of fiscal 2015 ended June 27, 2015, after the close of market on NASDAQ on Wednesday, July 22, 2015.
An investment community conference call to talk about these results and Infinera’s outlook will be held the same day at 5:30 p.m. ET/2:30 p.m. PT and will be accessible live and on an archived basis as follows:
Infinera Corporation provides optical transport networking equipment, software, and services for telecommunications service providers, Internet content providers, cable operators, wholesale and enterprise carriers, research and education institutions, and government entities worldwide.
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), ended its Friday’s trading session with 4.27% gain, and closed at $4.88.
Catalyst Pharmaceuticals, Inc. (CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, declared the appointment of Gary Ingenito, M.D., Ph.D, as Chief Medical Officer. Dr. Ingenito has more than 25 years of experience leading pharmaceutical development for drugs and biologics. In this new role, he will oversee all clinical development programs, medical affairs, regulatory and other related functions. Dr. Ingenito will report to Dr. Steven Miller, Catalyst’s Chief Operating Officer and Chief Scientific Officer. Following Dr. Ingenito’s joining Catalyst, the current Chief Medical Officer, Charles Gorodetzky, M.D., Ph.D, will continue to serve as a consultant to the company.
Catalyst Pharmaceuticals, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting rare (orphan) neurological diseases and disorders. The company offers Firdapse, a proprietary form of amifampridine phosphate, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
